Latest Articlesddd

A New Gene Therapy Series Starts Today with Regenxbio

July 16, 2020 0

Beyond the firms that are speeding towards bringing prophylactic vaccines against the COVID-19 infection into the …

INmune Bio: A Novel Approach Towards Treating Alzheimer’s Disease

July 14, 2020 0

Alzheimer’s Disease Alzheimer’s Disease has proven very difficult to treat through many of the trials’ attempts …

There Is A Lot More To Say About the COVID-19 Vaccines

July 13, 2020 0

Pfizer and BioNTech Vaccines Were Granted FDA Fast Track Designation Against SARS-CoV-2 (COVID-19) A large Phase …

CRiSPR Therapeutics Stock is Skyrocketing

July 8, 2020 0

CRiSPR Therapeutics Rally  For those who wonder why CRiSPR Therapeutics (CRSP) is soaring we remind that …

A Novel Immunotherapy Approach for the Treatment of COVID-19

July 7, 2020 0

Corvus Pharmaceuticals: FDA Granted IND Application for COVID-19 Trial The United States FDA granted approval of Corvus …

Are We Saying Goodbye to Common Sense?

July 3, 2020 2

Prohost Letter #441 Biotechnology Companies’ Evaluations Are We Saying Goodbye to Common Sense? The SARS-CoV-2 Vaccines …

Prohost Biotech’s Decision About Akero Therapeutics

July 1, 2020 0

Akero Therapeutics Today we posted good news from Akero Therapeutics (AKRO) under News & Comments. The …

Akero Therapeutics’ Product Efruxifermin Demonstrates Strong Positive Results in NASH Patients

July 1, 2020 0

Akero Therapeutics Efruxifermin Positive Results in NASH Akero Therapeutics (AKRO) results of a 16-week analysis of secondary …

We Are Not Yet in Bizarro World

June 30, 2020 0

Unclear Reasoning for the Inovio Selloff Though Inovio (INO) announced positive interim clinical data of INO-4800 …

A Letter to Subscribers

June 30, 2020 0

A Letter to Subscribers The complex brutal circumstances we are currently living in has made it …

The COVID-19 Vaccines’ Developing Firms’ Bizarre Evaluations

June 26, 2020 0

Novel Coronavirus Vaccines and Wall Street Vaccines against novel coronavirus are recognized now as the only …

Inovio Received $71 Million in Funding from the U.S. Department of Defense

June 23, 2020 0

Inovio Received US DoD Funding for CELLECTRA® 3PSP Smart Device Inovio (INO) announced today it has …

The Time Has Come for Agenus to Excel. See Also: Why Evoke Pharma Traded UP Today

June 22, 2020 0

Agenus Has Two Separate Press Releases In the First Press Release from Agenus: Agenus (AGEN) announced …

Good News for Four Companies: Jazz, Celldex, Inventiva & Illumina

June 17, 2020 0

Good News for Jazz, Celldex, Inventiva & Illumina Jazz Pharmaceuticals Good News Jazz Pharmaceuticals (JAZZ) announced along with …

Illumina’s COVIDSeq Test Granted Emergency Use Authorization. See Also: CRISPR Therapeutics and Vertex Encouraging News

June 15, 2020 0

Illumina Diagnostic Test COVIDSeq to Detect SARS-CoV-2 Illumina (ILMN) was issued an Emergency Use Authorization (EUA) …

Celldex Therapeutics: The Beginning of the Firm’s Resurrection

June 12, 2020 0

Celldex Therapeutics A few years ago Celldex Therapeutics (CLDX) was known for its superior pipeline products. …

Reata Pharmaceuticals Stock Soared

June 11, 2020 0

Reata Pharmaceuticals Stock is Flying High Here is another example of why analysts can no longer …

Moderna Speeding Towards Delivering the Awaited Novel Coronavirus Prophylactic Vaccine

June 11, 2020 0

Moderna mRNA-1273 Vaccine for COVID-19  The market is expected to open DOWN today. Moderna’s (MRNA) stock …

Has the Time Come for Curis Inc to Flex Its Muscles?

June 10, 2020 0

Curis Inc IND Application Cleared by the US FDA Curis Inc (CRIS) announced that the U.S. …

A Potential Merger Between AstraZeneca Plc and Gilead Sciences?

June 8, 2020 0

AstraZeneca Plc and Gilead Sciences Potential Merger News spread through the media announcing that AstraZeneca Plc …